BalticVC’s Post

Any QLD based startups in the agtech or climate tech space see below. Feel free to DM me if you have any questions

🎤 Great to have Carol Tarr representing us at Icos Capital's Collaborative Summit on a panel discussing Net Zero Industrial Decarbonization Strategies. Carol touched upon subjects like true zero vs net zero, why we need a commodities market to bring about systems change and more. #impinv #Impactinvesting #netzero

This is truly a major and meaningful development for Vietnam's nascent agritech industry. Vietnam’s Techcoop has raised a $70-million Series A funding round in a mix of equity and debt, in what could be the largest Series A investment in a Southeast Asian agritech startup to date. In March, DealStreetAsia first reported that the Ho Chi Minh City-based agritech startup secured over $5 million in equity and debt from local banks. The equity financing was co-led by AVV and TNB Aura through its TNBA Scout initiative for Vietnam. Ethos Ventures, South Korean impact investor MYSC, and Mandala Capital also participated in the fundraising. Read more at 👇 https://lnkd.in/giuUSpFd

Momentum like this doesn’t happen every week. Antiverse is leading, delivering, and doing it with a powerful vision: 💥 Secured €4.2 million in funding – investors know a winning team when they see one (led by i&i Biotech Fund & Kadmos Capital Ltd with Innospark Ventures, UKI2S/Future Planet Capital, Tensor Ventures, and AngelHub Ventures). 🎯 Hit a major multi-target milestone. Not just checking boxes; they’re making waves.  💰 Closed a contract with Nxera Pharma. This partnership is going to disrupt the field.  📰 Featured in The Times. They see the potential, and so does the world. This is a growth story. Antiverse is on the rise, setting the bar high, and they're just getting started. Big things ahead by Murat Tunaboylu, Ben H., along with the team & Pico! Read more about our portfolio startups in our newsletter: 🔗 https://lnkd.in/dygRtkwJ & on Antiverse's journey on Substack: https://lnkd.in/dc8p8xXc

Capital last week Ovoko \ RRR.LT 🇱🇹 closed Series B - EUR 20m from Smash Capital - marking Lithuania’s largest startup investment of 2024. ÄIO 🇪🇪 has raised EUR 6.1m from Voima Ventures, 2C Ventures, SmartCap and Nordic Foodtech VC. The funds will be used to build a demo plant in Estonia to produce environmentally friendly oils and fats from wood and agricultural residues. Mifundo 🇪🇪 closes round led by Tera Ventures, joined by Opus11 VC, Mihkel Karu (ex-Skype) and Sergei Anikin (ex-Pipedrive). It is EUR 1.2m pre-seed round, but Mifundo also secured EUR 8.8m with grants (EIC and other) FIRSTPICK, Change Ventures, and HEARTFELT_ are investing EUR 0.7m in Certific 🇪🇪 - they optimize workflows for clinics. Orion Securities invested in Statzon 🇫🇮 ,a subscription-based market intelligence platform from Finland.

🚀 Exciting Partnership Announcement! 🚀 We are delighted to unveil a strategic collaboration between TS Ventures Fund and SEE UP Accelerator aimed at driving innovation and fostering growth across key sectors in Southeast Europe. This partnership has just been signed by Davor Sakač, Uh (Unicorn Hunter) of TS Ventures, and Dusan Obradovic CEO of SEE UP. SEE UP Accelerator will serve as a pivotal deal flow of top-tier startups for TS Ventures, focusing on groundbreaking hardware and software solutions in Health, Pet Industry, FMCG, and BioTech. SEE UP Accelerator, a new initiative in the SEE region, is preparing to launch its inaugural cohort this year. It aims to empower startups with dedicated business development and sales support, leveraging its extensive network of distributors. Together, TS Ventures and SEE UP are poised to elevate innovation in Southeast Europe's most promising industries. Stay tuned as we embark on this journey of discovery, partnership, and groundbreaking achievements! 🚀 #TSVentures #SEEUP #Accelerator #Innovation #VentureCapital #SoutheastEurope #SEE #Partnership #StartupAccelerator #BioTech #Health #FMCG #PetIndustry

Hadean Ventures is a European life science fund manager with a particular focus on the Nordic region. The firm invests broadly across the life science sectors, especially in pharmaceutical and Digital Health. Hadean Ventures also has offices in Oslo and Stockholm. As for their investment activities, Hadean Ventures focuses on investing in early-stage life science startups across Europe, focusing on startups that have the highest growth potential and the lowest number of competitors. The investors at Hadean Ventures, are all well-experienced and only select startups that can generate 4x ROI within 3 years. The investment range of Hadean Ventures lies between $50,000 to $300,000.

Join us for an inspiring conversation with Markus Dietrich, PhD representing Hadean Ventures, a leading European life science venture capital firm with approximately EUR 230 million in assets under management. Hadean Ventures focuses on supporting innovative startups across the healthcare sector, particularly in the Nordics and German-speaking regions, with an emphasis on addressing unmet medical needs.   In this interview, Markus shares insights into the firm’s investment strategy and their hands-on approach to working with startups.

A valuable overview for all impact supporters. A deeper look at trends, the growth of impact-driven startups in the Baltics, and the ecosystem driving their success🚀

😇 superangels x Gründerszene 💙 Our very own #superangel Florian Gottschaller just shared some insights about our one-of-a-kind fund strategy and why we are convinced that our approach will have tremendous impact on early stage angel investing. 🎯 Florian lines out how investors have the opportunity to benefit from our network and the expertise of our trusted superangels; minimizing the risks of individual angel tickets via our fund that invests in 120-150 early stage startups. He shared with #Gründerszene what our core strategy is all about, what makes business angels #supersuccessful, and also his personal lessons learned from early angel investments 💥 💙 We strongly believe that it all comes down to the fact that - in its very core - Venture Capital is not an asset class, it is an access class: Those who have access to the best deals will be the ones achieving best returns. And with #superangels we make the best deals accessible to a bigger audience! 🌟 Curious to learn more? Check out the full article via link in comments👇🏼 🌟Anna Alex, Johannis Hatt, Prof. Dr. Roland Fassauer, Stefan Menden, Katja Ruhnke, Conny Hörl, Jan Dzulko, Martin Ostermayer, Florian Huber, Björn Jopen, Manuel Bönisch, Sebastian Johnston, Christoph Zoeller, Volker Rofalski, Marc Müller, Rudy Rüdiger Fajen, Dr. Axel Brunn, Dr.-Ing. Claudia Nagel, Daniel Bronk, Marc Schuler 🌟 😇 Franzi Majer 😇 Alexander Brand 😇